NAFDAC Recalls Substandard Drugs Over Health Risks
The National Agency for Food and Drug Administration and Control (NAFDAC) has ordered the recall of substandard batches of Amoxicillin oral suspension, Annmox, and Jawamox, manufactured by Jawa International Limited in Lagos. The drugs failed quality tests, posing health risks, especially to children.
NAFDAC advises healthcare providers and pharmacies to stop dispensing the affected products and urges the public to report any suspected substandard medicines. Consumers are advised to check batch numbers carefully and return the products for proper disposal.
NAFDAC reaffirms its commitment to ensuring the circulation of safe and quality medicines.
Plus234Feed summary based on reporting from The Will. Read the original report below.
Read full article
Continue on The Will
Get the week in one email
Top stories, NPFL results, the naira — every Friday morning. Free, one email a week.
Related Stories
NAFDAC Recalls Substandard Antibiotics Over Safety Concerns
NAFDAC Issues Alert on Falsified Betaclox Antibiotic in Nigeria
NAFDAC Issues Urgent Warning Over Fake Betaclox Antibiotic in Nigeria
NAFDAC Withdraws Approvals for 101 Products in Nigeria
NAFDAC Warns Nigerians of Fake Betaclox Antibiotic Threat
NAFDAC Warns of Substandard Edible Oils in Nigeria, Urges Vigilance
Get Plus234Feed on messaging apps
Same headlines, delivered where you already scroll.
